KIFLAM-MR

Comprehensive Analysis of Kiflam-MR Tablets

Overview

Kiflam-MR is a potent, triple-combination pharmacological formulation developed by Solvista Healthcare. It is specifically engineered to provide “Powerful Relief from Pain & Muscle Spasm.” The medication represents a multi-modal approach to musculoskeletal therapy, combining an analgesic, an antipyretic, and a skeletal muscle relaxant to address the complex nature of acute physical discomfort and inflammation.

Pharmacological Composition

Kiflam-MR is composed of three active ingredients that work synergistically to provide comprehensive relief:

1. Aceclofenac: A non-steroidal anti-inflammatory drug (NSAID) that works by inhibiting the cycloxygenase (COX) enzymes, which are responsible for the production of prostaglandins. Prostaglandins are the primary mediators of pain, swelling, and inflammation in the body.
2. Paracetamol (Acetaminophen): A widely used analgesic and antipyretic agent. It complements Aceclofenac by elevating the overall pain threshold and reducing fever, which is often associated with inflammatory conditions.
3. Chlorzoxazone: A centrally acting skeletal muscle relaxant. It acts on the spinal cord and subcortical areas of the brain to inhibit multi-synaptic reflex arcs involved in producing and maintaining muscle spasms.

Key Therapeutic Benefits

The marketing and clinical profile of Kiflam-MR highlights several distinct advantages:

• Triple Combination for Enhanced Pain Relief: By combining three different mechanisms of action, Kiflam-MR provides a more robust therapeutic effect than single-ingredient medications.
• Effective Anti-Inflammatory Action: Through the inclusion of Aceclofenac, the product directly targets the root cause of swelling and tissue irritation.
• Relief of Muscle Spasm & Stiffness: The inclusion of Chlorzoxazone makes this particularly effective for “locked” muscles or tension-based pain where traditional painkillers alone might fail.
• Rapid Onset of Action: The formulation is designed for quick absorption, ensuring that patients experience relief shortly after administration—a critical factor in managing acute pain.
• Quality Assured Formulation: Solvista Healthcare emphasizes that this is a “Trusted & Quality Assured Formulation,” indicating adherence to strict pharmaceutical manufacturing standards.

Clinical Indications

Kiflam-MR is specifically indicated for the management of:

• Acute Musculoskeletal Pain: Including strains, sprains, and sports injuries.
• Inflammation: Reducing the redness, heat, and swelling associated with joint or tissue trauma.
• Muscle Spasm: Treating involuntary muscle contractions that cause significant discomfort and limited mobility.